Drug-Coated Balloon Flops for De Novo Coronary Lesions First adequately powered randomized trial suggests larger vessel disease isn't the right fit Sep 02, 2024
DOAC Monotherapy Bests Dual Antithrombotic Therapy for Afib Plus Coronary Disease Bleeding reduced -- without risk of ischemic events -- versus dual antithrombotic in Korean trial Sep 01, 2024
Nonsteroidal MRA Improves Outcomes in HFpEF, HFmrEF Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival Sep 01, 2024
TriClip's 'Soft' Benefits Affirmed in Severe Tricuspid Regurgitation Randomized trial "highly encouraging" for making patients feel and function better Aug 31, 2024
Potassium Strategy After Cardiac Bypass Grafting Doesn't Impact Afib Risk First randomized trial debunks common practice of tight control Aug 31, 2024
Women's 30-Year Heart Risk Can Be Predicted by Just Three Factors And two aren't in the standard cardiovascular risk prediction tool Aug 31, 2024
Amyloidosis Drug Improves Outcomes, Survival RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy Aug 30, 2024
For Your Patients: Understanding Inherited Cholesterol Disorders What to know about familial hypercholesterolemia Aug 13, 2024
Diagnosing Hypercholesterolemia When and how to screen, what the diagnostic levels are, and which secondary causes to watch for Aug 13, 2024
For Your Patients: What Is Alzheimer's Disease? This progressive neurodegenerative disease is the most common type of dementia Aug 08, 2024